Leadership Overview
Navitas Life Sciences has 4 executives leading key functions including strategy, marketing, operations, and risk management.
Driven by a commitment to patient safety, Navitas Life Sciences empowers organizations worldwide in advancing clinical research through technology-driven CRO services, leveraging extensive experience and industry-leading networks to ensure patient well-being at every development stage.
Driven by a commitment to patient safety, Navitas Life Sciences empowers organizations worldwide in advancing clinical research through technology-driven CRO services, leveraging extensive experience and industry-leading networks to ensure patient well-being at every development stage.
Leadership Roles at Navitas Life Sciences
Steve Ferdock - Chief Executive Officer
Steve Ferdock, the Chief Executive Officer at Navitas Life Sciences, directs the company's overall strategic vision and operational execution. Ferdock guides the organization's mission to empower pharmaceutical, biotechnology, and federal agencies in advancing clinical research and ensuring patient safety. This leadership involves fostering innovation across end-to-end and point services in Clinical, Regulatory, Data Management, and Pharmacovigilance. Ferdock's oversight ensures Navitas Life Sciences maintains its position as a technology-driven CRO, leveraging over 35 years of experience and industry-leading networks like pvnet®, labelnet®, and medtechnetTM. The Chief Executive Officer's focus extends to driving growth and maintaining strong relationships with key stakeholders, including H.I.G. Capital, while upholding the core principle of keeping patients at the heart of all operations. Steve Ferdock ensures the company's global operations across North America, Asia Pacific, Europe, and Latin America align with its strategic objectives and market impact.
Ns Shobana - Chief of Staff To Chief Executive Officer. Chief Risk Officer
Ns Shobana, the Chief of Staff To Chief Executive Officer. Chief Risk Officer at Navitas Life Sciences, provides critical strategic support to the CEO and directs the company's enterprise-wide risk management framework. Shobana ensures operational alignment with the CEO's vision, facilitating seamless execution of strategic initiatives across all departments, including Clinical, Regulatory, Data Management, and PV. As Chief Risk Officer, Shobana identifies, assesses, and mitigates potential risks, safeguarding the company's operations and reputation while supporting its mission to advance clinical research and patient safety. This dual role involves enhancing the efficiency of Navitas Life Sciences' end-to-end services and strengthening its industry-leading networks. Ns Shobana's leadership ensures that Navitas Life Sciences, backed by H.I.G. Capital, maintains robust governance and compliance across its global footprint in North America, Asia Pacific, Europe, and Latin America, reinforcing patient-centricity in all endeavors.
Paul Gilbert - Chief Operating Officer, Navitas Data Sciences
Paul Gilbert, the Chief Operating Officer, Navitas Data Sciences at Navitas Life Sciences, spearheads the operational excellence and strategic direction of the company's data science division. Gilbert oversees the end-to-end and point services within Clinical, Regulatory, Data Management, and PV, ensuring seamless integration and delivery for sponsors globally. This leadership role focuses on leveraging Navitas Life Sciences' 35 years of experience and proprietary networks, such as pvnet®, labelnet®, and medtechnetTM, to drive innovation in clinical research and patient safety. The Chief Operating Officer, Navitas Data Sciences ensures that the company's technology-driven approach, recognized by industry analysts, translates into tangible benefits for pharmaceutical, biotechnology, and federal organizations. Paul Gilbert's operational management extends across Navitas Life Sciences' international presence in North America, Asia Pacific, Europe, and Latin America, reinforcing the company's commitment to advancing life sciences and prioritizing patient well-being.
Deepa Jayakumar - Chief Marketing Officer
Deepa Jayakumar, the Chief Marketing Officer at Navitas Life Sciences, architects and executes the global marketing strategy. Jayakumar drives brand awareness and market positioning for Navitas Life Sciences' comprehensive suite of technology-driven CRO services, spanning Clinical, Regulatory, Data Management, and PV. This role involves translating the company's extensive experience and industry-leading networks, including pvnet®, labelnet®, and medtechnetTM, into compelling market narratives. The Chief Marketing Officer ensures that the company's value proposition resonates with pharmaceutical, biotechnology, non-profit organizations, and US Federal Agencies worldwide. Jayakumar's leadership focuses on highlighting Navitas Life Sciences' recognized capabilities in drug safety, clinical development platforms, and life sciences operations, as acknowledged by firms like IDC MarketScape and Everest Group. Deepa Jayakumar oversees initiatives that communicate the company's commitment to advancing clinical research and patient safety across its global presence in North America, Asia Pacific, Europe, and Latin America.
Explore Leadership Teams in Business Services
The Indian Council of Agricultural Research (ICAR) is a premier research organization under the Ministry of Agriculture and Farmers Welfare in India. It focuses on agricultural research, education, and extension services to enhance agricultural productivity and sustainability. ICAR serves a diverse clientele, including farmers, agricultural universities, and research institutions, aiming to improve agricultural practices and technologies. The council also engages in various initiatives and programs to promote innovation and knowledge transfer in the agricultural sector.
Company Leadership HK
SS
GH
RS
Founded in 2012, WCG measurably improves the quality and efficiency of clinical trials, helping biopharmaceutical companies, CROs, and institutions facilitate the development of new treatments and therapies for patients. The company is headquartered in Princeton, New Jersey.
Company Leadership SS
EC
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of genes at the molecular level. The company also provides pathology consultation services for clients in which its pathologists review surgical samples on a consultative basis; and testing services in support of its pharmaceutical clients oncology programs, as well as acts as a reference laboratory supplying anatomic pathology testing services. NeoGenomics is headquartered in Fort Myers, Florida.
Company Leadership DO
Founded in 1985, Pharmaceutical Product Development (PPD) is a contract research organization engaging in drug discovery, development and lifecycle management for clients from pharmaceutical, biotechnological, medical device, academic and government organizations.
Company Leadership LE
FS
MW
Frequently Asked Questions Regarding Navitas Life Sciences Top Executives and Leadership Team
